SCHEMBL7537157

SCHEMBL7537157

CC(C)(C)OC(=O)C=CC(=O)OC1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.40
EPHX1 P07099 4/20 0.40
CYP19A1 P11511 2/20 0.39
NR1H4 Q96RI1 2/20 0.37
GAA P10253 1/20 0.36
HTT P42858 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CACNA1B Q00975 1/20 0.36
CYP2C19 P33261 1/20 0.34
HPGD P15428 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29676897 1.00 NAAA (0.40) NAAAEPHX1CYP19A1NR1H4GAA
SCHEMBL3516768 1.00 NAAA (0.40) NAAAEPHX1CYP19A1NR1H4GAA
SCHEMBL21614507 0.98 NAAA (0.39) NAAAEPHX1CYP19A1NR1H4GAA
Ethane SCHEMBL28092403 0.85 EPHX1 (0.47) NAAAEPHX1CYP19A1HTTNPC1
SCHEMBL7539573 0.84 EPHX1 (0.48) NAAAEPHX1CYP19A1HTTSMN1; SMN2
SCHEMBL22092280 0.84 EPHX1 (0.48) NAAAEPHX1CYP19A1HTTSMN1; SMN2
SCHEMBL780366 0.84 EPHX1 (0.48) NAAAEPHX1CYP19A1HTTSMN1; SMN2
SCHEMBL8101682 0.84 EPHX1 (0.48) NAAAEPHX1CYP19A1HTTSMN1; SMN2
SCHEMBL8101691 0.84 EPHX1 (0.48) NAAAEPHX1CYP19A1HTTSMN1; SMN2
SCHEMBL10386170 0.84 EPHX1 (0.48) NAAAEPHX1CYP19A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240010606-A1 FUMARATE DERIVATIVES AND THEIR MEDICAL USE SITRYX THERAPEUTICS LIMITED (GB) 2024-01-11 US disclosed
EP-4200275-A2 FUMARATE DERIVATIVES AND THEIR MEDICAL USE Sitryx Therapeutics Limited (GB) 2023-06-28 EP disclosed
WO-2022038365-A9 FUMARATE DERIVATIVES AND THEIR MEDICAL USE SITRYX THERAPEUTICS LIMITED (GB) 2022-07-14 WO disclosed
WO-2022038365-A2 NOVEL COMPOUNDS SITRYX THERAPEUTICS LIMITED (GB) 2022-02-24 WO disclosed
US-20020190818-A1 High frequency band pass filter TDK CORPORATION (JP) 2002-12-19 US disclosed
EP-0788118-B1 Low dielectric polymer and film, substrate and electronic part using the same TDK CORP (JP) 2002-11-20 EP disclosed
US-5914283-A FUMARIC ACID DIESTER MONOMER-CONTAINING POLYMER FILM; HEAT RESISTANCE, WEATHER RESISTANCE TDK CORPORATION (JP) 1999-06-22 US disclosed
EP-0722959-B1 Highly oxygen-permeable heat-resistant material MENICON CO LTD (JP) 1998-04-08 EP disclosed
EP-0788118-A1 Low dielectric polymer and film, substrate and electronic part using the same TDK Corporation (JP) 1997-08-06 EP disclosed
EP-0722959-A2 Highly oxygen-permeable heat-resistant material Menicon Co., Ltd. (JP) 1996-07-24 EP disclosed
EP-0524557-B1 Ocular lens material MENICON CO LTD (JP) 1996-01-17 EP disclosed
US-5391591-A A curable additional copolymer molding materials having a styrenic monomer, a hydrophilic acrylamide monomer and a crosslinkable vinylbenzyl acrylate monomer; permselectivity, tensile strength, low water absorption MENICON CO., LTD. (JP) 1995-02-21 US disclosed
US-5250583-A Polymer of fluoroalkyl silicon-containing alkyl fumarate, N-vinyllactam, acrylic or methacrylic acid, crosslinkable monomer MENICON CO., LTD. (JP) 1993-10-05 US disclosed
EP-0524557-A2 Ocular lens material Menicon Co., Ltd. (JP) 1993-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240010606-A1 FUMARATE DERIVATIVES AND THEIR MEDICAL USE FH, SUCNR1, ARG2 NAAA 3153/4885EPHX1 1163/4885CYP19A1 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.